Lidwine W. Tick

Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial

Mette S. van Ramshorst, Anna van der Voort, Erik van Werkhoven et al. · The Lancet Oncology · 2018 · 445 citations · Full text

Medicine, Oncology, Breast Oncology +15

Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study

Maarten P. Mourits, M. Loes van Kempen-Harteveld, M Begoña García García et al. · The Lancet · 2000 · 291 citations

Medicine, Oncology, Radiation Oncology +5

Further validation and simplification of the Wells clinical decision rule in pulmonary embolism

Maaike Söhne, Marieke J.H.A. Kruip, Lidwine W. Tick et al. · Thrombosis and Haemostasis · 2007 · 238 citations · Full text

Medicine, Biostatistics, Clinical Decision Support +16

Risk factors for post‐thrombotic syndrome in patients with a first deep venous thrombosis

Lidwine W. Tick, Mark H.H. Kramer, Frits R. Rosendaal et al. · Journal of Thrombosis and Haemostasis · 2008 · 224 citations · Full text

Medicine, Hematology, Surgery +15

Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial

Pascale Notten, Arina J. ten Cate‐Hoek, Carsten W. K. P. Arnoldussen et al. · The Lancet Haematology · 2019 · 219 citations · Full text

Medicine, Cardiology, Hemostasis +12